These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6154594)

  • 1. The in vitro effect of aprotinin upon spleen cells from normal and tumour-bearing mice exposed to PPD and tumour cells.
    Freeman JG; Latner AL; Turner GA; Venables CW
    Experientia; 1980 Feb; 36(2):247-9. PubMed ID: 6154594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trasylol (aprotinin) as an anti-tumour agent.
    Tweedie DJ; Thomson AW; Horne CH
    Biomedicine; 1978 Feb; 29(1):1-3. PubMed ID: 307409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in lymphoreticular tissues during growth of a murine adenocarcinoma. 3. Plaque-forming cell response in lymph nodes and spleen.
    Rowland GF; Edwards AJ; Hurd CM; Sumner MR
    J Natl Cancer Inst; 1971 Aug; 47(2):321-7. PubMed ID: 4934422
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of aprotinin on immunological resistance in tumour-bearing animals.
    Latner AL; Turner GA
    Br J Cancer; 1976 May; 33(5):535-8. PubMed ID: 1084153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purified protein derivative of tuberculin induces immunoglobulin production in normal mouse spleen cells.
    Nilsson BS; Sultzer BM; Bullock WW
    J Exp Med; 1973 Jan; 137(1):127-39. PubMed ID: 4120093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-cell susceptibility to cytotoxic or cytostatic effector cells in vitro and the regulation of tumour-cell growth in vivo.
    Gorczynski RM; MacRae S
    Br J Cancer; 1981 Jan; 43(1):32-43. PubMed ID: 7459235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of macrophages in the mechanism mediating the enhancement of metastasis formation after tumour resection.
    Yunker VM; Taraskina NP; Ustinov AS
    Biomed Sci; 1991; 2(6):569-75. PubMed ID: 1841624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of adenocarcinoma by the immunological consequences of calorie restriction.
    Fernandes G; Yunis EJ; Good RA
    Nature; 1976 Oct; 263(5577):504-7. PubMed ID: 1085916
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitory and stimulatory effect of spleen cells from tumour bearing animals on the growth of syngeneic tumour cells.
    Larsen FS; Spärck JV
    Acta Pathol Microbiol Scand C; 1978 Jun; 86C(3):131-9. PubMed ID: 716926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fc receptor-bearing and phagocytic cells in syngeneic tumours of C. parvum- and carrageenan-treated mice.
    Thomson AW; Cruickshank N; Fowler EF
    Br J Cancer; 1979 May; 39(5):598-602. PubMed ID: 486317
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro immune interferon induction during tumor evolution.
    Kohan S; Lustig ES; Teyssié AR; Tous M; Ayerra B
    Biomed Pharmacother; 1986; 40(4):150-3. PubMed ID: 3098317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of tumour growth in two syngeneic C3H murine systems by immunization via the intracaecal route.
    Laursen ML; Laursen K
    Br J Cancer; 1978 Jun; 37(6):1039-45. PubMed ID: 678425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of a tumour in F1 mice partially inhibits the GvH reaction following injection of parental spleen cells.
    Whitmarsh-Everiss T; Symes MO
    Br J Cancer; 1981 Mar; 43(3):305-11. PubMed ID: 7225282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented induction of tumor-specific resistance by priming with Mycobacterium tuberculosis (TBC) and subsequent immunization with PPD-coupled syngeneic tumor cells.
    Takatsu K; Hamaoka T; Tominaga A; Kanamasa Y
    J Immunol; 1980 Dec; 125(6):2367-73. PubMed ID: 6776192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumour activity of aprotinin.
    Latner AL; Longstaff E; Turner GA
    Br J Cancer; 1974 Jul; 30(1):60-7. PubMed ID: 4547138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immunity to mammary tumor virus in normal and tumor-bearing C3H/HeN mice.
    Tagliabue A; Herberman RB; McCoy JL
    Cancer Res; 1978 Aug; 38(8):2279-84. PubMed ID: 208765
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of isolated tumor lymphocytes alone and with adherent cells.
    Blazar BA; Galili N; Klein E
    Cancer Immunol Immunother; 1984; 18(3):179-84. PubMed ID: 6568875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age- and sex-related differences in antibody formation and blastogenic responsiveness of splenocytes from RIII mice developing virus-induced mammary adenocarcinoma.
    Specter S; Friedman H
    J Natl Cancer Inst; 1981 Dec; 67(6):1347-51. PubMed ID: 6273637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor cells in mice with murine mammary tumor virus-induced mammary tumors. I. Inhibition of mitogen-induced lymphocyte stimulation.
    Rudczynski AB; Mortensen RF
    J Natl Cancer Inst; 1978 Jan; 60(1):205-11. PubMed ID: 203703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The activity of nonspecific bone marrow and spleen suppressors in the latent period of tumor growth].
    Ogreba VI; Kusmartsev SA; Vasil'ev NV
    Vopr Onkol; 1988; 34(8):952-5. PubMed ID: 2971291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.